Jeremy Vernon Elwes

The Foundation for Liver Research, founded in 1974, conducts research on liver diseases and aims to use multi-omic biological data for diagnostics, management stratification, and therapeutic design. The non-profit company is based in London, UK. The British company's research includes susceptibility to bacterial infection in liver failure patients, mechanisms of neutrophil dysfunction, and hydrogen sulphide as a novel therapy. The company also focuses on in silico models and primary liver cancer.